FDA Drug Application (022321) for EMBEDA by ALPHARMA PHARMS

Back to FDA Applications sponsored by ALPHARMA PHARMS

Application Number022321
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG;0.8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMBEDA
Active IngredientMORPHINE SULFATE; NALTREXONE HYDROCHLORIDE



Back to FDA Applications sponsored by ALPHARMA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.